NeuroScientific readies stem cell supply boost for bowel disease trials

NeuroScientific Biopharmaceuticals is transferring stem cell production for its StemSmart therapy to Q-Gen in Brisbane to scale up supply for upcoming Crohn's disease clinical trials. The move represents a significant step in advancing stem cell-based treatments for bowel disease.